Drugs for rare disorders-Reference-Cited by-同舟云学术

Drugs for rare disorders

Published:2017-06-27 Issue:8 Volume:83 Page:1607-1613
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Cremers Serge¹,Aronson Jeffrey K.²^ORCID

Affiliation:

1. Departments of Pathology & Cell Biology and Medicine, and Irving Institute for Clinical and Translational Research; Columbia University Medical Center; New York NY 10027 USA

2. Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences; Radcliffe Infirmary; Woodstock Road Oxford, OX2 6GG UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13331/fullpdf

Reference83 articles.

1. Orphadata Free access data from Orphanet http://www.orphadata.org

2. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink;Carr;Clin Pharmacol Ther,2013

3. Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity;Alfirevic;Pharmacogenomics,2012

4. Orphan drugs: legal aspects, current situation;Lavandeira;Haemophilia,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Translation of Nanomedicines in the Contexts of Spinal Cord Injury and Repair;Cells;2024-03-24

2. A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases;Scientific Reports;2023-11-08

3. Role of pharmacists in the context of rare diseases: a scoping review protocol;BMJ Open;2023-11

4. Measuring Effectiveness of Treatments in Rare Disorders, Evidence from Clinical Trials in Fragile X Syndrome;2023-10-23

5. A novelin silicoscaffold-hopping method for drug repositioning in rare and intractable diseases;2023-07-04